These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of verteporfin pharmakokinetics--redefining the need of photosensitizers in ophthalmology. Ziemssen F, Heimann H. Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):1023-41. PubMed ID: 22762303 [Abstract] [Full Text] [Related]
5. Photodynamic therapy in the treatment of choroidal neovascularization complicating central serous chorioretinopathy. Yang CS, Chen KC, Lee SM, Lee FL. J Chin Med Assoc; 2009 Sep; 72(9):501-5. PubMed ID: 19762322 [Abstract] [Full Text] [Related]
7. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Pryds A, Larsen M. Acta Ophthalmol; 2012 Dec; 90(8):738-43. PubMed ID: 21586096 [Abstract] [Full Text] [Related]
18. The role of photodynamic therapy in the treatment of symptomatic choroidal hemangioma. Jurklies B, Bornfeld N. Graefes Arch Clin Exp Ophthalmol; 2005 May; 243(5):393-6. PubMed ID: 15700182 [No Abstract] [Full Text] [Related]
19. Photodynamic therapy of experimental choroidal neovascularization in the mouse. Odergren A, Ming Y, Kvanta A. Curr Eye Res; 2006 Sep; 31(9):765-74. PubMed ID: 16966149 [Abstract] [Full Text] [Related]